Physician

Matthew Thomas Finn, M.D,

According to 2025 Medicare claims, Matthew Finn, M.D, (NPI: 1376868000) practices interventional cardiology in the Houma-Bayou Cane-Thibodaux, LA market, with the plurality of this provider's patient population coming from Terrebonne, LA. This provider's primary affiliated billing organization is CARDIOVASCULAR INSTITUTE OF THE SOUTH, LLC (NPI: 1982689113; TIN: 720993441) and primary practice location at 70360-4413. Finn is affiliated with the Ochsner Accountable Care Network, LLC (ACO ID: A1535) and NewYork Quality Care (ACO ID: A2571), participating under the MSSP model.

Finn's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 826 traditional Medicare patients, billed 6,077 HCPCS/CPT codes, and received $232,190 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 5,575 prescription claims across 924 beneficiaries totaling $1,176,992 in drug costs, led by Eliquis (Apixaban). DME data shows 64 claims. Open Payments data shows 87 records totaling $21,864. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $91,970 to $232,190. Similarly, Part D prescription costs have risen steadily, from $25,574 to $1,176,992. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	220	954	$91,970
2016	180	892	$79,813
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	69	144	$12,073
2020	190	487	$68,402
2021	268	806	$108,254
2022	668	1,956	$116,060
2023	887	3,977	$216,166
2024	826	6,077	$232,190

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	39	554	$25,574
2016	20	101	$10,210
2017	25	264	$22,274
2018	23	192	$15,670
2019	16	59	$4,646
2020	95	437	$93,404
2021	234	1,897	$338,148
2022	332	2,128	$421,193
2023	458	2,752	$635,450
2024	924	5,575	$1,176,992

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	64	64	$53,258

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	157	160	$94
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	223	406	$86
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	119	143	$63
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	272	551	$12
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	358	448	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	205	10,325	$199,167
Xarelto	Rivaroxaban	175	9,200	$169,283
Mounjaro	Tirzepatide	134	4,256	$163,528
Repatha Sureclick	Evolocumab	170	7,452	$148,531
Ozempic	Semaglutide	82	3,102	$106,730

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0651	Pneumatic compressor, segmental home model without calibrated gradient pressure	N	32	32	$31,438
E0667	Segmental pneumatic appliance for use with pneumatic compressor, full leg	N	32	32	$21,819

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	86	$10,364	AngioDynamics, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$11,500	Janssen Research & Development, LLC
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Matthew Thomas Finn, M.D, ?

Tedicare shows public-source Medicare data for Matthew Thomas Finn, M.D, (NPI 1376868000), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew Thomas Finn, M.D, have ACO affiliation data?

Matthew Thomas Finn, M.D, is shown with ACO affiliation data for Ochsner Accountable Care Network, LLC (MSSP, ACO ID A1535) and NewYork Quality Care (MSSP, ACO ID A2571).

What billing organization is linked to Matthew Thomas Finn, M.D, ?

Matthew Thomas Finn, M.D, is linked to CARDIOVASCULAR INSTITUTE OF THE SOUTH, LLC (billing NPI 1982689113) in the available physician profile data.

Does Matthew Thomas Finn, M.D, have Open Payments data?

Matthew Thomas Finn, M.D, has 87 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.